AZYO Insider Trading Activity and SEC Form 4 Filings
AZYO insider trading summary
No open-market insider purchases or sales of Aziyo Biologics, Inc. (AZYO) have been reported on SEC Form 4 in the past 12 months.
Latest AZYO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 27, 2023 | Matthew Strobeck | 10% Owner | Buy | $16K (10,000 @ $1.59) |
| Mar 27, 2023 | Birchview Capital, LP | 10% Owner | Buy | $16K (10,000 @ $1.59) |
| Mar 27, 2023 | Birchview Fund LLC | 10% Owner | Buy | $16K (10,000 @ $1.59) |
| Mar 24, 2023 | Birchview Capital, LP | 10% Owner | Buy | $24K (18,000 @ $1.35) |
| Mar 24, 2023 | Birchview Fund LLC | 10% Owner | Buy | $24K (18,000 @ $1.35) |
| Mar 24, 2023 | Birchview Fund LLC | 10% Owner | Buy | $3K (2,000 @ $1.35) |
| Mar 24, 2023 | Birchview Capital, LP | 10% Owner | Buy | $3K (2,000 @ $1.35) |
| Mar 24, 2023 | Matthew Strobeck | 10% Owner | Buy | $24K (18,000 @ $1.35) |
| Mar 24, 2023 | Matthew Strobeck | 10% Owner | Buy | $3K (2,000 @ $1.35) |
| Mar 23, 2023 | Birchview Fund LLC | 10% Owner | Buy | $15K (10,000 @ $1.49) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.